Popping the Gross-to-Net Bubble, Part IV: Extreme Examples of Who Grew the Bubble
Pharmaceutical Commerce
JUNE 13, 2025
Those patients would lose insurance coverage/access to those products, but the PBM was contractually obligated to keep the product on formulary for the other 85% of lives. The loophole I just described was what he used to process that increase. Some companies saw this as a winning commercial decision. to $750 per pill.
Let's personalize your content